Search results

20 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Bobby Kadis: Living life to the fullest
These days Bobby Kadis is living life to the fullest. After being diagnosed with Stage 4 lung cancer, he enrolled in a UNC Lineberger clinical trial using a combination of targeted drug therapies. Now the avid potter, mountain climber and yoga enthusiast celebrates being cancer-free.
Located in News
Richard Boucher, Jr.
MD, Professor, UNC-Chapel Hill, Cancer Cell Biology
Located in People
Goldstein, McCullough address needed measures to curb tobacco use
Located in News / 2011 News
Kicking off Lung Cancer Awareness Month at the LUNGe Forward 5K
UNC Cancer Care thoracic oncologists joined the Lung Cancer Initiative's Raleigh LUNGe Forward 5K Run, Walk & Rally on November 1, 2014 in Raleigh, NC.
Located in News
Lung cancer highlights from 2011, Weiss provides insight
Jared Weiss, MD, gave a podcast titled "2011 Highlights in Lung Cancer" that was posted on cancergrace.org on March 15, 2012. In the podcast, Dr. Weiss talks about highlights in lung cancer from 2011 and also answers questions.
Located in News / 2012 News
Lung Cancer Initiative of NC Hosts 4th Lung Cancer Advocacy Summit
The Lung Cancer Initiative of NC hosted a statewide Lung Cancer Summit on August 23 at the N.C. Cancer Hospital. Lung cancer advocates were bolstered with training, resources, knowledge and the courage to take action. UNC Lineberger Comprehensive Cancer Center was the Host Sponsor of the event.
Located in News
Major named American Cancer Society Research Scholar
The American Cancer Society (ACS) has named Ben Major, PhD, assistant professor with the University of North Carolina School of Medicine and UNC Lineberger Comprehensive Cancer Center member, as a 2014 Research Scholar.
Located in News
Molecular subtypes and genetic alterations may determine response to lung cancer therapy
Chapel Hill - Cancer therapies targeting specific molecular subtypes of the disease allow physicians to tailor treatment to a patient’s individual molecular profile. But scientists are finding that in many types of cancer the molecular subtypes are more varied than previously thought and contain further genetic alterations that can affect a patient’s response to therapy.
Located in News / 2012 News
Pecot named one of only two ACS Mentored Research Scholar awardees
Chad Pecot, MD, assistant professor in hematology and oncology, has received a Mentored Research Scholar Award in Applied and Clinical Research from the American Cancer Society (ACS). Dr. Pecot is one of only two recipients in the United States to receive the award.
Located in News
Predictive biomarkers for lung cancer reported in laboratory finding
A team of scientists, including several from UNC Lineberger, has identified predictive genetic biomarkers in pre-clinical models that affect response to therapy for non-small cell lung cancer (NSCLC). The study was done in parallel to an ongoing clinical trial among lung cancer patients at multiple institutions.
Located in News / 2012 News